SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 50.51+0.6%11:22 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (2500)1/10/2001 2:46:11 AM
From: Londo   of 52153
 
FYI, INCY's subsidary, Diadexus finally priced their IPO today at 12-14 bucks a share. Assuming $13/share after the offering, that implies a market cap of $404.3 million.

INCY will own 14.1% of the holding, or roughly 57 million bucks of DDXS. This is roughly 4% of INCY's present market cap of 1.5 billion.

To be honest, this is quite a bit more than I thought they would get out of it. My mind was thinking $200 million cap at most..

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News